178 related articles for article (PubMed ID: 26931765)
1. Analgesic Effects Mediated by Muscarinic Receptors: Mechanisms and Pharmacological Approaches.
De Angelis F; Tata AM
Cent Nerv Syst Agents Med Chem; 2016; 16(3):218-226. PubMed ID: 26931765
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic pain pharmacology: realizing the promise of novel analgesics by overcoming old challenges.
Fiorino DF; Garcia-Guzman M
Handb Exp Pharmacol; 2012; (208):191-221. PubMed ID: 22222700
[TBL] [Abstract][Full Text] [Related]
3. New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
Greig NH; Reale M; Tata AM
Recent Pat CNS Drug Discov; 2013 Aug; 8(2):123-41. PubMed ID: 23597304
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review.
Wess J; Duttaroy A; Gomeza J; Zhang W; Yamada M; Felder CC; Bernardini N; Reeh PW
Life Sci; 2003 Mar; 72(18-19):2047-54. PubMed ID: 12628455
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice.
Duttaroy A; Gomeza J; Gan JW; Siddiqui N; Basile AS; Harman WD; Smith PL; Felder CC; Levey AI; Wess J
Mol Pharmacol; 2002 Nov; 62(5):1084-93. PubMed ID: 12391271
[TBL] [Abstract][Full Text] [Related]
6. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.
Gomeza J; Zhang L; Kostenis E; Felder CC; Bymaster FP; Brodkin J; Shannon H; Xia B; Duttaroy A; Deng CX; Wess J
Life Sci; 2001 Apr; 68(22-23):2457-66. PubMed ID: 11392613
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological approaches to targeting muscarinic acetylcholine receptors.
Matera C; Tata AM
Recent Pat CNS Drug Discov; 2014; 9(2):85-100. PubMed ID: 25413004
[TBL] [Abstract][Full Text] [Related]
8. Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity.
Matera C; Flammini L; Quadri M; Vivo V; Ballabeni V; Holzgrabe U; Mohr K; De Amici M; Barocelli E; Bertoni S; Dallanoce C
Eur J Med Chem; 2014 Mar; 75():222-32. PubMed ID: 24534538
[TBL] [Abstract][Full Text] [Related]
9. Analgesic and antineuropathic drugs acting through central cholinergic mechanisms.
Bartolini A; Di Cesare Mannelli L; Ghelardini C
Recent Pat CNS Drug Discov; 2011 May; 6(2):119-40. PubMed ID: 21585331
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.
Wess J; Eglen RM; Gautam D
Nat Rev Drug Discov; 2007 Sep; 6(9):721-33. PubMed ID: 17762886
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats.
Chen SR; Pan HL
J Pharmacol Exp Ther; 2003 Nov; 307(2):676-81. PubMed ID: 12966147
[TBL] [Abstract][Full Text] [Related]
12. Broad analgesic activity of a novel, selective M1 agonist.
Wood MW; Martino G; Coupal M; Lindberg M; Schroeder P; Santhakumar V; Valiquette M; Sandin J; Widzowski D; Laird J
Neuropharmacology; 2017 Sep; 123():233-241. PubMed ID: 28623171
[TBL] [Abstract][Full Text] [Related]
13. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord.
Naguib M; Yaksh TL
Anesth Analg; 1997 Oct; 85(4):847-53. PubMed ID: 9322468
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic acetylcholine receptors: new potential therapeutic targets in antinociception and in cancer therapy.
Tata AM
Recent Pat CNS Drug Discov; 2008 Jun; 3(2):94-103. PubMed ID: 18537768
[TBL] [Abstract][Full Text] [Related]
15. On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease.
Koch HJ; Haas S; Jürgens T
Curr Med Chem; 2005; 12(24):2915-21. PubMed ID: 16305479
[TBL] [Abstract][Full Text] [Related]
16. Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.
Takasu K; Honda M; Ono H; Tanabe M
Br J Pharmacol; 2006 May; 148(2):233-44. PubMed ID: 16582934
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease.
Clader JW; Wang Y
Curr Pharm Des; 2005; 11(26):3353-61. PubMed ID: 16250841
[TBL] [Abstract][Full Text] [Related]
18. Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.
Mirza NR; Peters D; Sparks RG
CNS Drug Rev; 2003; 9(2):159-86. PubMed ID: 12847557
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptors and novel strategies for the treatment of age-related brain disorders.
Ehlert FJ; Roeske WR; Yamamura HI
Life Sci; 1994; 55(25-26):2135-45. PubMed ID: 7997072
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogs.
Sauerberg P; Olesen PH; Sheardown MJ; Suzdak PD; Shannon HE; Bymaster FP; Calligaro DO; Mitch CH; Ward JS; Swedberg MD
Life Sci; 1995; 56(11-12):807-14. PubMed ID: 10188779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
